KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent TaxesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ionis Pharmaceuticals (IONS) Intangibles: 2009-2022

Historic Intangibles for Ionis Pharmaceuticals (IONS) over the last 13 years, with Sep 2022 value amounting to $29.6 million.

  • Ionis Pharmaceuticals' Intangibles fell 1.44% to $29.6 million in Q3 2022 from the same period last year, while for Sep 2022 it was $29.6 million, marking a year-over-year decrease of 1.44%. This contributed to the annual value of $29.0 million for FY2021, which is 3.82% up from last year.
  • According to the latest figures from Q3 2022, Ionis Pharmaceuticals' Intangibles is $29.6 million, which was up 1.90% from $29.1 million recorded in Q2 2022.
  • In the past 5 years, Ionis Pharmaceuticals' Intangibles registered a high of $30.0 million during Q3 2021, and its lowest value of $22.9 million during Q1 2018.
  • Over the past 3 years, Ionis Pharmaceuticals' median Intangibles value was $29.0 million (recorded in 2021), while the average stood at $28.7 million.
  • Per our database at Business Quant, Ionis Pharmaceuticals' Intangibles grew by 12.31% in 2019 and then declined by 1.44% in 2022.
  • Ionis Pharmaceuticals' Intangibles (Quarterly) stood at $24.0 million in 2018, then rose by 6.83% to $25.7 million in 2019, then climbed by 8.81% to $27.9 million in 2020, then rose by 3.82% to $29.0 million in 2021, then declined by 1.44% to $29.6 million in 2022.
  • Its Intangibles was $29.6 million in Q3 2022, compared to $29.1 million in Q2 2022 and $29.3 million in Q1 2022.